• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

可切除胰腺癌的营养状况与化疗完成情况：一项叙述性综述

Nutritional Status and Chemotherapy Completion in Resectable Pancreatic Cancer: A Narrative Review.

作者信息

Funamizu Naotake, Uraoka Mio, Ito Chihiro, Iwata Miku, Sakamoto Akimasa, Kamei Yoshiaki, Umeda Yuzo

机构信息

Department of Hepatobiliary Pancreatic and Breast Surgery, Graduate School of Medicine, Ehime University, Shitsukawa 454, Toon-City 791-0295, Ehime Prefecture, Japan.

出版信息

Curr Oncol. 2025 Sep 17;32(9):519. doi: 10.3390/curroncol32090519.

DOI:10.3390/curroncol32090519
PMID:41002589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12468601/
Abstract

In this review, we define "malnutrition" according to the Global Leadership Initiative on Malnutrition (GLIM) criteria (phenotypic and etiologic components) and "cachexia" as a multifactorial syndrome characterized by progressive skeletal muscle loss-unresponsive to conventional nutrition-and systemic inflammation (e [...].

摘要

在本综述中，我们根据营养不良全球领导倡议（GLIM）标准（表型和病因学组成部分）定义“营养不良”，并将“恶病质”定义为一种多因素综合征，其特征为进行性骨骼肌丢失（对传统营养无反应）和全身炎症（e [...]. ）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/1f4fd4d72458/curroncol-32-00519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/89c0af8dfb29/curroncol-32-00519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/8d694ab86f44/curroncol-32-00519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/1f4fd4d72458/curroncol-32-00519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/89c0af8dfb29/curroncol-32-00519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/8d694ab86f44/curroncol-32-00519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/12468601/1f4fd4d72458/curroncol-32-00519-g003.jpg

相似文献

1
Nutritional Status and Chemotherapy Completion in Resectable Pancreatic Cancer: A Narrative Review.可切除胰腺癌的营养状况与化疗完成情况：一项叙述性综述
Curr Oncol. 2025 Sep 17;32(9):519. doi: 10.3390/curroncol32090519.
2
Current status of the association between malnutrition defined by the GLIM criteria and postoperative outcomes in gastrointestinal surgery for cancer: a narrative review.GLIM标准定义的营养不良与胃肠道癌手术术后结局之间的关联现状：一项叙述性综述
J Cancer Res Clin Oncol. 2023 Apr;149(4):1635-1643. doi: 10.1007/s00432-022-04175-y. Epub 2022 Jul 8.
3
The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis.LDH 与癌症恶病质 GLIM 标准的关系：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2024 Jul;199:104378. doi: 10.1016/j.critrevonc.2024.104378. Epub 2024 May 14.
4
Global Leadership Initiative on Malnutrition cachexia: an inflammation-first approach for the diagnosis of disease-related malnutrition.全球营养不良恶液质领导倡议：以炎症为首要的疾病相关营养不良诊断方法。
Curr Opin Clin Nutr Metab Care. 2024 Sep 1;27(5):393-396. doi: 10.1097/MCO.0000000000001052. Epub 2024 Aug 8.
5
Validity of the GLIM criteria for the diagnosis of malnutrition in patients with colorectal cancer: A multicenter study on the diagnostic performance of different indicators of reduced muscle mass and disease severity.GLIM标准在结直肠癌患者营养不良诊断中的有效性：一项关于肌肉量减少和疾病严重程度不同指标诊断性能的多中心研究
Nutrition. 2024 Mar;119:112324. doi: 10.1016/j.nut.2023.112324. Epub 2023 Dec 6.
6
Complementarity of nutrition risk screening tools with malnutrition diagnosis in patients with cancer: A 12-month follow-up study assessing accuracy metrics and mortality.癌症患者营养风险筛查工具与营养不良诊断的互补性：一项评估准确性指标和死亡率的12个月随访研究
Nutr Clin Pract. 2025 Oct;40(5):1166-1177. doi: 10.1002/ncp.11295. Epub 2025 Apr 16.
7
Relationship between global leadership initiative on malnutrition (GLIM) defined malnutrition and survival, length of stay and post-operative complications in people with cancer: A systematic review.全球营养不良领导倡议（GLIM）定义的营养不良与癌症患者的生存、住院时间和术后并发症的关系：系统评价。
Clin Nutr. 2023 Mar;42(3):255-268. doi: 10.1016/j.clnu.2023.01.012. Epub 2023 Jan 13.
8
The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma.营养在营养不良的癌症患者中的作用：重新审视一个老难题。
Clin Nutr. 2024 Jun;43(6):1320-1328. doi: 10.1016/j.clnu.2024.03.018. Epub 2024 Apr 10.
9
Implementation of the GLIM (Global Leadership Initiative on Malnutrition) Criteria in Gastrointestinal Oncology: A Narrative Review of Systemic Impact and the Role of Dietitians.全球营养不良领导倡议（GLIM）标准在胃肠肿瘤学中的应用：对系统影响及营养师作用的叙述性综述
Cureus. 2025 Jun 26;17(6):e86826. doi: 10.7759/cureus.86826. eCollection 2025 Jun.
10
Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review.恶病质、化疗与老年癌症患者结局的相关性：一项系统综述。
Clin Nutr. 2017 Dec;36(6):1473-1482. doi: 10.1016/j.clnu.2016.12.003. Epub 2016 Dec 18.

本文引用的文献

1
Geriatric nutritional risk index predicts postoperative outcomes in elderly patients with pancreatoduodenectomy: a propensity score-matched analysis.老年营养风险指数预测老年胰十二指肠切除术患者的术后结局：一项倾向评分匹配分析
Gland Surg. 2025 May 30;14(5):807-817. doi: 10.21037/gs-2024-541. Epub 2025 May 27.
2
Combined effect of frailty and sarcopenia on postoperative complications in older adults undergoing curative surgery for hepato-biliary-pancreatic cancer.衰弱和肌肉减少症对接受肝胆胰癌根治性手术的老年人术后并发症的联合影响。
Ann Gastroenterol Surg. 2024 Dec 24;9(3):587-594. doi: 10.1002/ags3.12897. eCollection 2025 May.
3
Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study.
新型改良衰弱指数在一项双中心研究中预测可切除胰腺癌辅助化疗的完成情况。
Sci Rep. 2025 May 16;15(1):17000. doi: 10.1038/s41598-025-02365-5.
4
Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curative Surgery for Pancreatic Ductal Adenocarcinoma: A Cohort Study with External Validation.术后老年营养风险指数作为胰腺导管腺癌根治性切除术后对S-1辅助化疗耐受性的决定因素：一项外部验证的队列研究
Cancers (Basel). 2025 Apr 26;17(9):1448. doi: 10.3390/cancers17091448.
5
Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.吉西他滨联合S-1新辅助化疗与直接手术治疗可切除胰腺癌的比较：随机II/III期Prep-02/JSAP05试验结果
Ann Surg. 2025 Apr 16. doi: 10.1097/SLA.0000000000006730.
6
The prognostic impact of preoperative nutritional status on postoperative complications and overall survival in patients with resectable pancreatic cancer.可切除胰腺癌患者术前营养状况对术后并发症及总生存期的预后影响。
Support Care Cancer. 2025 Mar 3;33(3):240. doi: 10.1007/s00520-025-09303-1.
7
Research progress on the mechanism and treatment of cachexia based on tumor microenvironment.
Nutrition. 2025 May;133:112697. doi: 10.1016/j.nut.2025.112697. Epub 2025 Feb 1.
8
Geriatric Nutritional Risk Index (GNRI) and Survival in Pancreatic Cancer: A Retrospective Study.老年营养风险指数（GNRI）与胰腺癌患者生存率：一项回顾性研究
Nutrients. 2025 Jan 30;17(3):509. doi: 10.3390/nu17030509.
9
Pancreatic exocrine insufficiency after pancreatic resection: a systematic review.胰腺切除术后的胰腺外分泌功能不全：一项系统综述
BMC Surg. 2025 Feb 3;25(1):53. doi: 10.1186/s12893-025-02787-y.
10
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.TTI-101（一种首创的STAT3口服抑制剂）用于晚期实体瘤患者的I期试验。
Clin Cancer Res. 2025 Mar 17;31(6):965-974. doi: 10.1158/1078-0432.CCR-24-2920.